HRP20110861T1 - Lijek za liječenje gripe - Google Patents

Lijek za liječenje gripe Download PDF

Info

Publication number
HRP20110861T1
HRP20110861T1 HR20110861T HRP20110861T HRP20110861T1 HR P20110861 T1 HRP20110861 T1 HR P20110861T1 HR 20110861 T HR20110861 T HR 20110861T HR P20110861 T HRP20110861 T HR P20110861T HR P20110861 T1 HRP20110861 T1 HR P20110861T1
Authority
HR
Croatia
Prior art keywords
enopyranozoic
tetradeoxy
galacto
glycero
guanidino
Prior art date
Application number
HR20110861T
Other languages
English (en)
Croatian (hr)
Inventor
Yamashita Makoto
Kawaoka Yoshihiro
Original Assignee
Daiichi Sankyo Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Company filed Critical Daiichi Sankyo Company
Publication of HRP20110861T1 publication Critical patent/HRP20110861T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
HR20110861T 2007-03-07 2011-11-21 Lijek za liječenje gripe HRP20110861T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007056872 2007-03-07
PCT/JP2008/053738 WO2008108323A1 (ja) 2007-03-07 2008-03-03 インフルエンザ治療剤

Publications (1)

Publication Number Publication Date
HRP20110861T1 true HRP20110861T1 (hr) 2011-12-31

Family

ID=39738201

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110861T HRP20110861T1 (hr) 2007-03-07 2011-11-21 Lijek za liječenje gripe

Country Status (17)

Country Link
US (2) US20100204314A1 (de)
EP (1) EP2123271B1 (de)
JP (2) JP5286251B2 (de)
KR (1) KR101473028B1 (de)
CN (1) CN101715343B (de)
AT (1) ATE526960T1 (de)
CA (1) CA2680415A1 (de)
CY (1) CY1112201T1 (de)
DK (1) DK2123271T3 (de)
ES (1) ES2372996T3 (de)
HK (1) HK1137142A1 (de)
HR (1) HRP20110861T1 (de)
PL (1) PL2123271T3 (de)
PT (1) PT2123271E (de)
SI (1) SI2123271T1 (de)
TW (1) TWI424841B (de)
WO (1) WO2008108323A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
US8680020B2 (en) 2008-07-15 2014-03-25 Academia Sinica Glycan arrays on PTFE-like aluminum coated glass slides and related methods
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
CN103068378B (zh) * 2010-05-10 2016-07-06 中央研究院 具有抗流感活性的扎那米韦膦酸酯同类物及其制备方法
CN105037309A (zh) * 2011-12-16 2015-11-11 第一三共株式会社 用于制备神经氨酸衍生物的方法
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
CA2880701A1 (en) 2012-08-18 2014-02-27 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
WO2014210397A1 (en) 2013-06-26 2014-12-31 Academia Sinica Rm2 antigens and use thereof
US9981030B2 (en) 2013-06-27 2018-05-29 Academia Sinica Glycan conjugates and use thereof
CA2923579C (en) 2013-09-06 2023-09-05 Academia Sinica Human inkt cell activation using glycolipids with altered glycosyl groups
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
TW201620939A (zh) 2014-01-16 2016-06-16 中央研究院 治療及檢測癌症之組合物及方法
JP6562942B2 (ja) 2014-03-27 2019-08-28 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 反応性標識化合物およびその使用
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
JP2017518989A (ja) 2014-05-27 2017-07-13 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 抗ｃｄ２０糖操作抗体群およびその使用
WO2015184008A1 (en) 2014-05-27 2015-12-03 Academia Sinica Fucosidase from bacteroides and methods using the same
AU2015267045B2 (en) 2014-05-27 2021-02-25 Academia Sinica Anti-HER2 glycoantibodies and uses thereof
TWI732738B (zh) 2014-05-28 2021-07-11 中央研究院 抗TNF-α醣抗體及其用途
CA2960712A1 (en) 2014-09-08 2016-03-17 Academia Sinica Human inkt cell activation using glycolipids
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
JP6779887B2 (ja) 2015-01-24 2020-11-04 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 新規なグリカンコンジュゲートおよびその使用方法
CN109195996A (zh) 2016-03-08 2019-01-11 中央研究院 N-聚醣及其阵列的模组化合成方法
CA3034057A1 (en) 2016-08-22 2018-03-01 CHO Pharma Inc. Antibodies, binding fragments, and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3209946B2 (ja) * 1996-07-22 2001-09-17 三共株式会社 ノイラミン酸誘導体
ATE211468T1 (de) * 1996-07-22 2002-01-15 Sankyo Co Neuraminsäuredervate, ihre herstellung und medizinische verwendung
US6340702B1 (en) 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
US6451766B1 (en) 1996-07-22 2002-09-17 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
JP4151800B2 (ja) 1996-08-13 2008-09-17 第一三共株式会社 ノイラミン酸化合物
JP3920041B2 (ja) * 2000-04-25 2007-05-30 三共株式会社 ノイラミン酸化合物の水和物及び結晶
TWI291462B (en) 2000-04-25 2007-12-21 Daiichi Sankyo Co Ltd Hydrate crystal of neuraminic acid compound
ATE414215T1 (de) 2005-08-22 2008-11-15 Delphi Tech Inc Nockenwellenversteller zur einstellung der phase zwischen einer nockenwelle und einem antriebsrad

Also Published As

Publication number Publication date
PL2123271T3 (pl) 2012-03-30
EP2123271A4 (de) 2010-03-17
EP2123271B1 (de) 2011-10-05
TWI424841B (zh) 2014-02-01
WO2008108323A1 (ja) 2008-09-12
TW200848018A (en) 2008-12-16
JPWO2008108323A1 (ja) 2010-06-17
CN101715343A (zh) 2010-05-26
JP5286251B2 (ja) 2013-09-11
US20140018418A1 (en) 2014-01-16
KR20090129414A (ko) 2009-12-16
SI2123271T1 (sl) 2012-05-31
EP2123271A1 (de) 2009-11-25
JP6012076B2 (ja) 2016-10-25
ATE526960T1 (de) 2011-10-15
PT2123271E (pt) 2011-12-20
HK1137142A1 (en) 2010-07-23
JP2013139483A (ja) 2013-07-18
US20100204314A1 (en) 2010-08-12
ES2372996T3 (es) 2012-01-30
KR101473028B1 (ko) 2014-12-15
CA2680415A1 (en) 2008-09-12
DK2123271T3 (da) 2012-01-23
CN101715343B (zh) 2012-09-26
CY1112201T1 (el) 2015-12-09

Similar Documents

Publication Publication Date Title
HRP20110861T1 (hr) Lijek za liječenje gripe
RS53236B (en) BETA-AMYLOIDOSIS PEPTIDES
EA201101190A1 (ru) Фармацевтическая композиция, включающая линаглиптин и необязательно ингибитор sglt2, и ее применение
ECSP10010548A (es) Composiciones y metodos de preparacion y uso de las mismas
EA201200550A1 (ru) Фармацевтические композиции, включающие bi-1356 и метформин
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
RS53124B (en) USE OF BETANECOL FOR THE TREATMENT OF XEROSOMOMY
ATE386534T1 (de) Orale darreichungsform enthaltend probiotische bakterien
EA201200631A1 (ru) Ингибиторы репликации вируса иммунодефицита человека
CL2009000316A1 (es) Compuestos derivados de urea de benzomorfanos y sus sales, inhibidores de la enzima 11-beta-hidroxiesteroide deshidrogenasa; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de trastornos metabolicos.
CL2007002346A1 (es) Compuestos no nucleosidicos derivados de fenoxi-fenil sustituidos, inhibidores de la transcriptasa inversa del vih; composicion farmaceutica; y su uso para tratar prevenir una infeccion vih o para tratar el sida o crs.
RS54123B1 (en) THERAPEUTIC COMBINATION CONTAINING DOLUTEGRAVIR, ABACAVIR AND LAMIVUDINE
CY1112813T1 (el) 4-(4-κυανο-2-θειοαρυλ)διϋδροπυριμιδινονες και η χρηση αυτων
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
UY31145A1 (es) Derivado de 17b+ciano-18a-homo-19-nor-androst-4-eno, su uso y medicamento que lo contiene
ATE534378T1 (de) Titrierung von tapentadol
CL2009000349A1 (es) Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
PA8720801A1 (es) Nuevas combinaciones terapeuticas para el tratamiento de la depresion
CR11684A (es) Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa
RS54158B1 (en) AMILOID BINDING AGENTS
BRPI0815920A2 (pt) Composto, composição farmacêutica, e, uso do composto.
MX2010001849A (es) Depsipeptidos ciclicos.
CL2007000918A1 (es) Compuestos derivados de enfumafungina, inhibidores de (1,3)-beta-d-glucanosintetasa; composicion farmaceutica; y uso para tratar una infeccion fungica.
CY1116840T1 (el) Χρηση 24-norudca
MA32841B1 (fr) Composés de cycloundeca depsipeptides et leur utilisation comme médicament